Valentin Huerva Escanilla

Esteve-Boncompte, G; Sánchez-Quin, A; Morant, Y; VILARDELL, F; Soria, X; Torrente, RM; Jaria, M; Huerva, V; Marti, RM

Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series

DERMATOLOGY 1-8. 01/08/2026.

[doi:10.1159/000553517]

Vilaltella, M; Serés-Noriega, T; Cid-Bertomeu, P; Huerva, V

Evaluation of Intraocular Lens Power Calculation Formulas for Highly Myopic Eyes: A Systematic Review and Network Meta-Analysis

Journal of Clinical Medicine 15 -. 24/07/2026.

[doi:10.3390/jcm15155792]

Cid-Bertomeu, P; Vilaltella, M; Capilla, L; Huerva, V

Impact of Diabetic Peripheral Neuropathy on Corneal Sensitivity and Ocular Surface

OPHTHALMIC RESEARCH 69 56-63. 01/01/2026.

[doi:10.1159/000550306]

Vilaltella, M; Cid-Bertomeu, P; Serés-Noriega, T; Huerva, V

Response to Comment on: Accuracy of 12 IOL power calculation formulas in highly myopic eyes

INTERNATIONAL OPHTHALMOLOGY 45 480-480. 15/11/2025.

[doi:10.1007/s10792-025-03842-6]

Vilaltella, M; Cid-Bertomeu, P; Serés-Noriega, T; Huerva, V

Accuracy of 12 IOL power calculation formulas in highly myopic eyes

INTERNATIONAL OPHTHALMOLOGY 45 -. 25/06/2025.

[doi:10.1007/s10792-025-03608-0]

Cid-Bertomeu, P; Vilaltella, M; Martínez, M; Mir, M; Huerva, V

Topical Insulin for Ocular Surface Disease

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 40 204-214. 22/03/2024.

[doi:10.1089/jop.2024.0016]

Vilaltella, M; Cid-Bertomeu, P; Huerva, V

Accuracy of 10 IOL power calculation formulas in 100 short eyes (= 22 mm)

INTERNATIONAL OPHTHALMOLOGY 43 2613-2622. 01/08/2023.

[doi:10.1007/s10792-023-02660-y]

Huerva V; Vilardell F; Cid-Bertomeu P

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

Case Reports in Ophthalmology 14 111-114. 22/03/2023.

[doi:10.1159/000529667]

Cid-Bertomeu P; Huerva V

Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.

SURVEY OF OPHTHALMOLOGY 67 1391-1404. 01/09/2022.

[doi:10.1016/j.survophthal.2022.03.003]

Huerva, V; Cid-Bertomeu, P; Espinet, R; Canto, LM

Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

Ocular Oncology and Pathology 8 88-92. 01/06/2022.

[doi:10.1159/000522195]

Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V

IgG(4)-related orbital disease

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. 01/06/2022.

Vilaltella, M; Huerva, V

The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA 85 109-114. 01/01/2022.

[doi:10.5935/0004-2749.20220018]